Measures administered pretreatment, during and post-treatment
| Measure | Baseline pretreatment | Session 19 | End of treatment | Weeks post-treatment | 24 weeks post-treatment |
| MIOS | X | X | X | X | X |
| MORIS | X | X | X | X | |
| PCL-5 | X | X | X | X | X |
| ITQ | X | X | X | X | |
| PHQ-9 | X | X | X | X | |
| DAR-5 | X | X | X | X | |
| AUDIT | X | X | X | X | |
| OSSS-3 | X | X | X | X | |
| SWEMWBS | X | X | X | X | |
| SF-12 | X | X | X | X | |
| MI memory perspective measure | X | X | X | X | |
| Health economics information | X | X | X |
MI Memory Perspective Measure=measure of MI memory perspective, adapted from Wells and Papageorgiou.52
AUDIT, Alcohol Use Disorders Identification Test; DAR-5, The Dimensions of Anger Reactions-5; ITQ, International Trauma Questionnaire ; MI, moral injury; MIOS, Moral Injury Outcome Scale; MORIS, Moral Injury Scale ; OSSS-3, Oslo Social Support Scale-3; PCL-5, PTSD Checklist for DSM-5 ; PHQ-9, Patient Health Questionnaire-9; SF-12, Short Form Health Survey ; SWEMWBS, Short Warwick-Edinburgh Mental Wellbeing Scale.